Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2061)
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
37
Price
$332.64
Total Value
$12.31K
Shares Held After
23,512
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
94
Price
$331.93
Total Value
$31.20K
Shares Held After
23,549
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
81
Price
$330.85
Total Value
$26.80K
Shares Held After
23,643
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
170
Price
$329.71
Total Value
$56.05K
Shares Held After
23,724
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
100
Price
$328.71
Total Value
$32.87K
Shares Held After
23,894
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
329
Price
$327.67
Total Value
$107.80K
Shares Held After
23,994
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
392
Price
$326.81
Total Value
$128.11K
Shares Held After
24,323
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
258
Price
$325.63
Total Value
$84.01K
Shares Held After
24,715
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
90
Price
$324.65
Total Value
$29.22K
Shares Held After
24,973
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
47
Price
$323.62
Total Value
$15.21K
Shares Held After
25,063
% of Holdings
0.2%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
4,198
Price
$1.43
Total Value
$6.00K
Shares Held After
170,736
% of Holdings
2.4%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
2,461
Price
$1.43
Total Value
$3.52K
Shares Held After
174,934
% of Holdings
1.4%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
3,068
Price
$1.43
Total Value
$4.39K
Shares Held After
177,395
% of Holdings
1.7%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
756
Price
$1.43
Total Value
$1.08K
Shares Held After
180,463
% of Holdings
0.4%
Penumbra Inc (PEN)
Yuen Maggie — Chief Financial Officer
Shares
2,432
Price
$342.30
Total Value
$832.47K
Shares Held After
18,353
% of Holdings
11.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
53
Price
$332.64
Total Value
$17.63K
Shares Held After
64,273
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
129
Price
$331.93
Total Value
$42.82K
Shares Held After
64,326
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
112
Price
$330.85
Total Value
$37.06K
Shares Held After
64,455
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
234
Price
$329.71
Total Value
$77.15K
Shares Held After
64,567
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
138
Price
$328.71
Total Value
$45.36K
Shares Held After
64,801
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
454
Price
$327.67
Total Value
$148.76K
Shares Held After
64,939
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
541
Price
$326.81
Total Value
$176.80K
Shares Held After
65,393
% of Holdings
0.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
356
Price
$325.63
Total Value
$115.92K
Shares Held After
65,934
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
124
Price
$324.65
Total Value
$40.26K
Shares Held After
66,290
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
65
Price
$323.62
Total Value
$21.04K
Shares Held After
66,414
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
42
Price
$332.64
Total Value
$13.97K
Shares Held After
25,181
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
101
Price
$331.93
Total Value
$33.52K
Shares Held After
25,223
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
87
Price
$330.85
Total Value
$28.78K
Shares Held After
25,324
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
182
Price
$329.71
Total Value
$60.01K
Shares Held After
25,411
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
107
Price
$328.71
Total Value
$35.17K
Shares Held After
25,593
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
353
Price
$327.67
Total Value
$115.67K
Shares Held After
25,700
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
421
Price
$326.81
Total Value
$137.59K
Shares Held After
26,053
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
277
Price
$325.63
Total Value
$90.20K
Shares Held After
26,474
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
97
Price
$324.65
Total Value
$31.49K
Shares Held After
26,751
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
50
Price
$323.62
Total Value
$16.18K
Shares Held After
26,848
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
578
Price
$70.46
Total Value
$40.73K
Shares Held After
767,780
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
15,322
Price
$69.80
Total Value
$1.07M
Shares Held After
768,358
% of Holdings
2.0%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
4,051
Price
$1.43
Total Value
$5.79K
Shares Held After
240,755
% of Holdings
1.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,100
Price
$69.20
Total Value
$283.71K
Shares Held After
783,680
% of Holdings
0.5%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
2,590
Price
$1.43
Total Value
$3.70K
Shares Held After
244,806
% of Holdings
1.0%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
4,433
Price
$1.43
Total Value
$6.34K
Shares Held After
247,396
% of Holdings
1.8%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
1,163
Price
$1.43
Total Value
$1.66K
Shares Held After
251,829
% of Holdings
0.5%
Vanda Pharmaceuticals Inc. (VNDA)
Moran Kevin Patrick — SVP, CFO & Treasurer
Shares
42,442
Price
$8.27
Total Value
$350.82K
Shares Held After
411,380
% of Holdings
9.4%
Vanda Pharmaceuticals Inc. (VNDA)
Williams Timothy — SVP & General Counsel
Shares
42,434
Price
$8.27
Total Value
$350.76K
Shares Held After
377,450
% of Holdings
10.1%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
66,363
Price
$28.14
Total Value
$1.87M
Shares Held After
793
% of Holdings
98.8%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
4,090
Price
$27.51
Total Value
$112.50K
Shares Held After
67,156
% of Holdings
5.7%
Vanda Pharmaceuticals Inc. (VNDA)
Wijkstrom Joakim — SVP, Chief Marketing Officer
Shares
30,800
Price
$8.27
Total Value
$254.59K
Shares Held After
333,469
% of Holdings
8.5%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
3,048
Price
$89.66
Total Value
$273.28K
Shares Held After
122,029
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
1,055
Price
$88.50
Total Value
$93.37K
Shares Held After
125,077
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
1,510
Price
$87.75
Total Value
$132.50K
Shares Held After
126,132
% of Holdings
1.2%
Showing 1701–1750 of 2061 transactions (page 35 of 42)